Works matching DE "OXYPHENBUTAZONE"

Results: 8

Effect on the human complement system of the major non--steroidal anti-inflammatory drugs: aspirin, indomethacin, phenylbutazone, oxyphenbutazone and sulindac.

Published in:

Clinical & Experimental Immunology, 1983, v. 53, n. 3, p. 555

By:

Minta, J. O.;
Urowitz, M. B.;
Smythe, H. A.;
Isenman, D. E.

Publication type:

Article

Oxyphenbutazone--Induced Parotitis.

Published in:

1969

By:

Gross, Ludwig

Publication type:

Case Study

Quantification of Several Acidic Drugs in Equine Serum Using LC-MS-MS.

Published in:

Journal of Analytical Toxicology, 2013, v. 37, n. 8, p. 600, doi. 10.1093/jat/bkt069

By:

Heffron, Brendan;
Taddei, Lisa;
Benoit, Marc;
Negrusz, Adam

Publication type:

Article

Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.

Published in:

2017

By:

Cavanaugh, Joseph S.;
Jou, Ruwen;
Mei-Hua Wu;
Dalton, Tracy;
Kurbatova, Ekaterina;
Ershova, Julia;
Cegielski, J. Peter;
Wu, Mei-Hua;
Global PETTS Investigators

Publication type:

journal article

Allergic contact dermatitis from oxyphenbutazone.

Published in:

Contact Dermatitis (01051873), 1985, v. 12, n. 4, p. 236, doi. 10.1111/j.1600-0536.1985.tb01126.x

By:

Pigatto, P. D.;
Riboldi, A.;
Morelli, M.;
Altomare, G. F.;
Polenghi, M. M.

Publication type:

Article

Contact sensitivity to oxyphenbutazone (Tanderil®) and cross-sensitivity to phenylbutazone (Butazolidin®).

Published in:

Contact Dermatitis (01051873), 1975, v. 1, n. 4, p. 262, doi. 10.1111/j.1600-0536.1975.tb05420.x

By:

Krook, Gösta

Publication type:

Article

The Analysis of Phenylbutazone and Its Active Metabolite, Oxyphenbutazone, in Equine Tissues (Muscle, Kidney, and Liver), Urine, and Serum by LC-MS/MS.

Published in:

Journal of AOAC International, 2017, v. 100, n. 4, p. 1110, doi. 10.5740/jaoacint.16-0127

By:

BOISON, JOE O.;
DOWLING, PATRICIA;
MATUS, JOHANNA L.;
KINAR, JANA;
JOHNSON, RON

Publication type:

Article

Oxyphenbutazone promotes cytotoxicity in rats and Hep3B cellsvia suppression of PGE<sub>2</sub> and deactivation of Wnt/β-catenin signaling pathway.

Published in:

Molecular & Cellular Biochemistry, 2018, v. 444, n. 1/2, p. 187, doi. 10.1007/s11010-017-3243-2

By:

Saleem, Shakir;
Khan, Ruqaiyah;
Afzal, Muhammad;
Kazmi, Imran

Publication type:

Article